Nephros Inc - NEPH STOCK NEWS

Nephros reported Q3 2024 financial results with net revenue of $3.5 million, marking an 8% increase over Q2 2024 but a 6% decrease from Q3 2023. The company achieved its first profitable quarter with net income of $0.2 million, compared to a net loss of $0.2 million in Q3 2023. Gross margins improved to 61% from 59% year-over-year. Adjusted EBITDA reached $295,000, up from $11,000 in the same period last year. Cash position stood at $2.5 million as of September 30, 2024, down from $4.3 million at the end of 2023.

Nephros (Nasdaq: NEPH), a water technology company specializing in filtration solutions for healthcare and commercial markets, announced it will release its third-quarter 2024 financial results on Thursday, November 7, 2024, after market close. The company will host a conference call at 4:30pm ET the same day. Participants can join via domestic access (1-844-808-7106) or international access (1-412-317-5285). An audio archive will be available on the Nephros Investor Relations page, with replay access until November 14, 2024.

Nephros (Nasdaq: NEPH) has launched the HydraGuard 20" UltraFilter, expanding its filtration technology portfolio. The new filter offers higher-volume capacity and flow rate while removing bacteria, viruses, and endotoxins. This product enables Nephros to enter new markets, particularly medical device manufacturing and pharmaceutical production, supporting compliance with water quality standards like ANSI/AAMI ST108.

The filter builds upon existing HydraGuard technology, previously to dialysis water purification, and provides exceptional retention of microbiological contaminants through size exclusion, offering more reliable performance compared to charged membranes.

Nephros, Inc. (Nasdaq: NEPH), a leader in advanced filtration technology, has responded rapidly to the recent hurricanes Helene and Milton that devastated parts of the southeastern United States. The company provided important water filtration solutions to multiple healthcare and nursing care facilities affected by the storms, ensuring a safe water supply for patients and staff during recovery efforts.

Nephros has shipped a significant number of filters, responding after hours and delivering next day to both federal and local disaster response partners. Their solutions have been deployed across multiple states and facility types, including:

• Florida hospitals where Nephros in-line filters were previously installed
• North Carolina nursing and care facilities where point-of-use filters provided immediate protection against bacteria

The company's ability to act quickly in disaster response situations underscores its commitment to clean water access, offering an effective alternative to typical emergency water sources.

Nephros (NEPH) reported Q2 2024 financial results with net revenue of $3.3 million, an 8% decrease from Q2 2023. However, programmatic revenue increased by 8% year-over-year, driven by over 300 new accounts added in the past 12 months. The company reported a net loss of $0.3 million, an improvement from $0.4 million in Q2 2023. Adjusted EBITDA was ($133,000), compared to ($183,000) in the prior year.

CEO Robert Banks highlighted growth in the core programmatic business but noted a decline in emergency response sales. The company is developing new business models to address challenges in filter changeout schedules. As of June 30, 2024, Nephros had cash and cash equivalents of $3.1 million.

Nephros Inc (Nasdaq: NEPH), a leading water technology company, has announced its schedule for the second quarter 2024 financial results conference call. The company will file its Q2 financial results on Thursday, August 8, 2024 after market close and host a conference call at 4:30pm ET the same day. Participants can join the call using the following dial-in numbers:

• Domestic access: 1 (844) 808-7106
• International access: 1 (412) 317-5285

An audio archive will be available on the Nephros Investor Relations page shortly after the call. A replay will also be accessible until August 15, 2024, using specific replay access codes for domestic and international callers.

Nephros, Inc. reports strong financial results for the fourth quarter and fiscal year ended December 31, 2023, with net revenue reaching $14.2 million for the year. The company saw a 43% increase in net revenue compared to the previous year, along with significant improvements in adjusted EBITDA. Nephros attributes its success to streamlined operations, a focus on filtration solutions, and strategic partnerships.

Nephros, Inc. (NEPH) to release Q4 and fiscal year financial results on March 7, 2024, followed by a conference call. The company offers filtration solutions for medical and commercial markets.

Nephros, Inc. (Nasdaq: NEPH) announces third-quarter net revenue of $3.7 million, a 55% increase over 2022, with net loss from continuing operations narrowing 85% to $0.2 million. The company also reports $1.1 million in positive year-to-date net cash flows from operating activities. The financial performance highlights include third-quarter adjusted EBITDA positive $11,000, compared to negative $304,000 in 2022.